All articles by GlobalData Healthcare

  1. Ipsen seeks candidates as it looks to spend over €1bn on pipeline growth

    Ipsen is actively scouting candidates to boost its oncology, rare disease and neuroscience portfolio, said chief business officer Ivana Magovčević-Liebisch. The…
    Read More…

    19 Oct
  2. NeuroActiva looks to raise up to $200m by mid-2019 for Alzheimer’s trial

    NeuroActiva is actively discussing either a large pharma partnership or a potential NASDAQ public listing (IPO) by mid-2019 to raise…
    Read More…

    18 Oct
  3. Lantern Project: Genzyme and PerkinElmer highlight lysosomal storage disorders

    For a disease group that cannot yet be cured, the administrations of therapies that slow the progression of the disease…
    Read More…

    18 Oct
  4. AZ’s Brexit freeze will be short-term, but UK pharma’s future remains unclear

    AstraZeneca announced this week that it would be freezing investment in its UK operations until greater clarity was provided over…
    Read More…

    17 Oct
  5. Europe’s updated guidelines on atopic dermatitis

    The latest update to the consensus-based European guidelines for the treatment of atopic dermatitis in adults and children was published…
    Read More…

    17 Oct
  6. How will the UK’s relaxed cannabis regulations impact clinical practice?

    The UK home secretary announced that as of November 1, specialist doctors will be given the option to legally prescribe…
    Read More…

    17 Oct
  7. Trial design should give Dermira’s AD drug a better shot at Phase IIb success

    Dermira’s lebrikizumab Phase IIb trial for atopic dermatitis (AD) has a better shot at statistical and clinical significance with the exclusion…
    Read More…

    16 Oct
  8. Roche’s Hemlibra: a (Bi)-specific shift in the hemophilia A market

    The hemophilia drug market is currently undergoing major changes due to advances in recombinant protein engineering, as well as the…
    Read More…

    16 Oct
  9. Roche makes a cautious investment in Ionis’ dAMD drug

    Following up on Roche’s first partnership with Ionis Pharmaceuticals for an early-stage pipeline asset for Huntington’s disease, the two companies…
    Read More…

    15 Oct
  10. ESMO 2018: previewing high-impact, late-breaking abstracts

    The 2018 European Society for Medical Oncology (ESMO) Annual Congress will begin in Munich on October 19, where combination therapies…
    Read More…

    15 Oct